Product Information
Name:BPR1K871
Synonyms:
- DBPR114
Brand:Targetmol
Description:BPR1K871, a preclinical development candidate for anti-cancer therapy [1], is a potent, selective dual inhibitor targeting FLT3 and AURKA, with IC50 values of
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:526.05
Formula:C25H28ClN7O2S
Color/Form:Solid
Technical inquiry about: BPR1K871
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please add the desired products to your cart and manage the request from there. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.